vs
Side-by-side financial comparison of ADVANCED ENERGY INDUSTRIES INC (AEIS) and Guardant Health, Inc. (GH). Click either name above to swap in a different company.
ADVANCED ENERGY INDUSTRIES INC is the larger business by last-quarter revenue ($489.4M vs $281.3M, roughly 1.7× Guardant Health, Inc.). ADVANCED ENERGY INDUSTRIES INC runs the higher net margin — 10.7% vs -45.7%, a 56.4% gap on every dollar of revenue. On growth, Guardant Health, Inc. posted the faster year-over-year revenue change (39.4% vs 17.8%). ADVANCED ENERGY INDUSTRIES INC produced more free cash flow last quarter ($43.0M vs $-54.2M). Over the past eight quarters, Guardant Health, Inc.'s revenue compounded faster (29.2% CAGR vs 22.2%).
Advanced Energy Industries, Inc. is an American multinational technology company headquartered in Denver, Colorado that develops precision power conversion, measurement and control technologies for the manufacture of semiconductors, flat panel displays, data storage products, telecommunications network equipment, industrial coatings, medical devices, solar cells and architectural glass.
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
AEIS vs GH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $489.4M | $281.3M |
| Net Profit | $52.3M | $-128.5M |
| Gross Margin | 38.6% | 64.6% |
| Operating Margin | 11.6% | -43.0% |
| Net Margin | 10.7% | -45.7% |
| Revenue YoY | 17.8% | 39.4% |
| Net Profit YoY | 7.4% | -15.8% |
| EPS (diluted) | $1.32 | $-1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $489.4M | $281.3M | ||
| Q3 25 | $463.3M | $265.2M | ||
| Q2 25 | $441.5M | $232.1M | ||
| Q1 25 | $404.6M | $203.5M | ||
| Q4 24 | $415.4M | $201.8M | ||
| Q3 24 | $374.2M | $191.5M | ||
| Q2 24 | $364.9M | $177.2M | ||
| Q1 24 | $327.5M | $168.5M |
| Q4 25 | $52.3M | $-128.5M | ||
| Q3 25 | $46.2M | $-92.7M | ||
| Q2 25 | $25.2M | $-99.9M | ||
| Q1 25 | $24.7M | $-95.2M | ||
| Q4 24 | $48.7M | $-111.0M | ||
| Q3 24 | $-14.9M | $-107.8M | ||
| Q2 24 | $15.0M | $-102.6M | ||
| Q1 24 | $5.4M | $-115.0M |
| Q4 25 | 38.6% | 64.6% | ||
| Q3 25 | 37.6% | 64.7% | ||
| Q2 25 | 37.0% | 65.0% | ||
| Q1 25 | 37.2% | 63.3% | ||
| Q4 24 | 37.2% | 61.6% | ||
| Q3 24 | 35.8% | 61.1% | ||
| Q2 24 | 35.0% | 59.1% | ||
| Q1 24 | 34.5% | 61.2% |
| Q4 25 | 11.6% | -43.0% | ||
| Q3 25 | 10.6% | -37.3% | ||
| Q2 25 | 7.2% | -45.9% | ||
| Q1 25 | 7.6% | -54.6% | ||
| Q4 24 | 8.2% | -62.4% | ||
| Q3 24 | -3.0% | -61.3% | ||
| Q2 24 | 3.6% | -56.8% | ||
| Q1 24 | 0.2% | -59.2% |
| Q4 25 | 10.7% | -45.7% | ||
| Q3 25 | 10.0% | -35.0% | ||
| Q2 25 | 5.7% | -43.0% | ||
| Q1 25 | 6.1% | -46.8% | ||
| Q4 24 | 11.7% | -55.0% | ||
| Q3 24 | -4.0% | -56.3% | ||
| Q2 24 | 4.1% | -57.9% | ||
| Q1 24 | 1.6% | -68.2% |
| Q4 25 | $1.32 | $-1.01 | ||
| Q3 25 | $1.20 | $-0.74 | ||
| Q2 25 | $0.67 | $-0.80 | ||
| Q1 25 | $0.65 | $-0.77 | ||
| Q4 24 | $1.29 | $-0.90 | ||
| Q3 24 | $-0.40 | $-0.88 | ||
| Q2 24 | $0.40 | $-0.84 | ||
| Q1 24 | $0.14 | $-0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $791.2M | $378.2M |
| Total DebtLower is stronger | $567.5M | $1.5B |
| Stockholders' EquityBook value | $1.4B | $-99.3M |
| Total Assets | $2.5B | $2.0B |
| Debt / EquityLower = less leverage | 0.42× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $791.2M | $378.2M | ||
| Q3 25 | $758.6M | $580.0M | ||
| Q2 25 | $713.5M | $629.1M | ||
| Q1 25 | $723.0M | $698.6M | ||
| Q4 24 | $722.1M | $525.5M | ||
| Q3 24 | $657.3M | $585.0M | ||
| Q2 24 | $986.1M | $933.7M | ||
| Q1 24 | $1.0B | $1.0B |
| Q4 25 | $567.5M | $1.5B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $564.7M | $1.1B | ||
| Q3 24 | $564.0M | — | ||
| Q2 24 | $907.3M | — | ||
| Q1 24 | $911.5M | — |
| Q4 25 | $1.4B | $-99.3M | ||
| Q3 25 | $1.3B | $-354.5M | ||
| Q2 25 | $1.3B | $-305.5M | ||
| Q1 25 | $1.2B | $-250.8M | ||
| Q4 24 | $1.2B | $-139.6M | ||
| Q3 24 | $1.2B | $-60.1M | ||
| Q2 24 | $1.2B | $-1.6M | ||
| Q1 24 | $1.1B | $68.3M |
| Q4 25 | $2.5B | $2.0B | ||
| Q3 25 | $2.4B | $1.3B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $2.3B | $1.3B | ||
| Q4 24 | $2.3B | $1.5B | ||
| Q3 24 | $2.2B | $1.5B | ||
| Q2 24 | $2.5B | $1.6B | ||
| Q1 24 | $2.5B | $1.7B |
| Q4 25 | 0.42× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.80× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.5M | $-26.4M |
| Free Cash FlowOCF − Capex | $43.0M | $-54.2M |
| FCF MarginFCF / Revenue | 8.8% | -19.3% |
| Capex IntensityCapex / Revenue | 7.7% | 9.9% |
| Cash ConversionOCF / Net Profit | 1.54× | — |
| TTM Free Cash FlowTrailing 4 quarters | $125.9M | $-233.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $-26.4M | ||
| Q3 25 | $78.7M | $-35.4M | ||
| Q2 25 | $45.2M | $-60.3M | ||
| Q1 25 | $28.9M | $-62.7M | ||
| Q4 24 | $82.7M | $-64.5M | ||
| Q3 24 | $34.1M | $-51.1M | ||
| Q2 24 | $6.7M | $-94.0M | ||
| Q1 24 | $7.3M | $-30.3M |
| Q4 25 | $43.0M | $-54.2M | ||
| Q3 25 | $50.8M | $-45.8M | ||
| Q2 25 | $17.1M | $-65.9M | ||
| Q1 25 | $15.0M | $-67.1M | ||
| Q4 24 | $69.9M | $-83.4M | ||
| Q3 24 | $21.4M | $-55.3M | ||
| Q2 24 | $-8.1M | $-99.1M | ||
| Q1 24 | $-9.3M | $-37.2M |
| Q4 25 | 8.8% | -19.3% | ||
| Q3 25 | 11.0% | -17.3% | ||
| Q2 25 | 3.9% | -28.4% | ||
| Q1 25 | 3.7% | -33.0% | ||
| Q4 24 | 16.8% | -41.3% | ||
| Q3 24 | 5.7% | -28.9% | ||
| Q2 24 | -2.2% | -55.9% | ||
| Q1 24 | -2.9% | -22.1% |
| Q4 25 | 7.7% | 9.9% | ||
| Q3 25 | 6.0% | 3.9% | ||
| Q2 25 | 6.4% | 2.4% | ||
| Q1 25 | 3.4% | 2.2% | ||
| Q4 24 | 3.1% | 9.4% | ||
| Q3 24 | 3.4% | 2.2% | ||
| Q2 24 | 4.0% | 2.9% | ||
| Q1 24 | 5.1% | 4.1% |
| Q4 25 | 1.54× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.79× | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 1.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AEIS
| Semiconductor Equipment | $211.6M | 43% |
| Data Center Computing | $177.9M | 36% |
| Industrial And Medical | $78.2M | 16% |
| Telecom And Networking | $21.7M | 4% |
GH
| Oncology | $189.9M | 68% |
| Biopharma Data | $54.0M | 19% |
| Screening | $35.1M | 12% |
| Licensing Other | $2.2M | 1% |
